Corticosteroids in severe pneumonia. A propensity score matching study based on real-life.

A. Ceccato (barcelona, Spain), A. Russo (Pisa, Italy), E. Barbeta (Barcelona, Spain), P. Oscanoa (Barcelona, Spain), G. Tiseo (Pisa, Italy), A. Gabarrus (Barcelona, Spain), P. Di Giannatale (Pescara, Italy), S. Nogas (Genoa, Italy), F. Menichetti (Pisa, Italy), M. Ferrer (Barcelona, Spain), M. Falcone (Pisa, Italy), A. Torres (Barcelona, Spain)

Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Session: Respiratory infections and bronchiectasis outcomes
Session type: Oral Presentation
Number: 2856

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ceccato (barcelona, Spain), A. Russo (Pisa, Italy), E. Barbeta (Barcelona, Spain), P. Oscanoa (Barcelona, Spain), G. Tiseo (Pisa, Italy), A. Gabarrus (Barcelona, Spain), P. Di Giannatale (Pescara, Italy), S. Nogas (Genoa, Italy), F. Menichetti (Pisa, Italy), M. Ferrer (Barcelona, Spain), M. Falcone (Pisa, Italy), A. Torres (Barcelona, Spain). Corticosteroids in severe pneumonia. A propensity score matching study based on real-life.. 2856

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Can seriousness of respiratory failure be predicted by the values of clinical score in patients with acute severe asthma?
Source: Eur Respir J 2001; 18: Suppl. 33, 73s
Year: 2001

Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEOS score.
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


A prospective study of the relationship of severity assessed by modified CURB-65 score and mortality in patients with commmunity acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006

A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013


Comparison of pneumonia severity scoring methods in identification of severe community acquired pneumonia
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017

Are severity scores for community acquired pneumonia being used in secondary care and its impact on appropriateness of antibiotic therapy - a retrospective study
Source: Eur Respir J 2004; 24: Suppl. 48, 187s
Year: 2004

The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia (CAP) in young patients: results from the CAPO international study
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008


An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


Evaluation of sequential organ failure assessment (SOFA) based models for predicting mortality in ICU patients
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Pneumonia severity assessment scores in COVID19 pneumonia; clinical validation in a pragmatic healthcare setting
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


Does the use of the CURB-65 score improve outcomes in community-acquired pneumonia (CAP)?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Time to move away from peak flows in severe asthma? A symptom based score that predicts exacerbations.
Source: International Congress 2017 – Monitoring asthma control
Year: 2017

Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006


A simple score for future risk prediction in patients with controlled asthma who undergo a step-down guidelines-based strategy.
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017



Is it possible to identify phenotypes of problematic severe asthma in children using fluctuation based clustering?
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016

Adult Malaysian patients with community-acquired pneumonia: comparing two severity scoring systems in predicting need for ventilation
Source: Eur Respir J 2007; 30: Suppl. 51, 677s
Year: 2007

A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study
Source: Eur Respir J, 56 (3) 2002113; 10.1183/13993003.02113-2020
Year: 2020



Baseline symptom scores and future risk of severe exacerbation: The SPARK study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Different definitions in childhood asthma: how dependable is the dependent variable?
Source: Eur Respir J 2010; 36: 48-56
Year: 2010